Q Code

All Codes   A Code   B Code   C Code   CPT Code   J Code   NOC Code   P Code   Q Code   S Code

NEURACEQ – Q9983

NEURACEQ is an Imaging/Radiopharmaceutical drug manufactured by Life Molecular Imaging and administered via the Intravenous route of administration. The Q Code: Q9983 is aligned to the drug NEURACEQ.

read more

CEREBYX – Q2009

CEREBYX is an Anti-Convulsant drug manufactured by Pfizer and administered via the Injection route of administration. The Q Code: Q2009 is aligned to the drug CEREBYX.

read more

Integra Bilayer Wound Matrix – Q4104

Integra Bilayer Wound Matrix is a Wound Care drug manufactured by Integra Lifesciences and administered via the Topical application route of administration. The Q Code: Q4104 is aligned to the drug Integra Bilayer Wound Matrix.

read more

Integra Omnigraft Dermal Regeneration Matrix – Q4105

Integra Omnigraft Dermal Regeneration Matrix is a Wound Care drug manufactured by Integra Lifesciences and administered via the Topical application route of administration. The Q Code: Q4105 is aligned to the drug Integra Omnigraft Dermal Regeneration Matrix.

read more

FERAHEME – Q0139

FERAHEME is an Anti-Anemia drug manufactured by Amag Pharmaceuticals and administered via the Intravenous route of administration. The Q Code: Q0139 is aligned to the drug FERAHEME.

read more

FERAHEME – Q0138

FERAHEME is an Anti-Anemia drug manufactured by Amag Pharmaceuticals and administered via the Intravenous route of administration. The Q Code: Q0138 is aligned to the drug FERAHEME.

read more

Alymsys – Q5126

Alymsys is an Oncology drug manufactured by Amneal Biosciences and administered via the Intravenous route of administration. The Q Code: Q5126 is aligned to the drug Alymsys.

read more

YESCARTA – Q2041

YESCARTA is an Oncology drug manufactured by Kite Pharma and administered via the Intravenous route of administration. The Q Code: Q2041 is aligned to the drug YESCARTA.

read more

TENIPOSIDE – Q2017

TENIPOSIDE is an Oncology drug manufactured by WG Critical Care and administered via the Intravenous route of administration. The Q Code: Q2017 is aligned to the drug TENIPOSIDE.

read more

ACTEMRA – Q0249

ACTEMRA is a COVID-19 drug manufactured by Genentech and administered via the Intravenous route of administration. The Q Code: Q0249 is aligned to the drug ACTEMRA.

read more

Sotrovimab Injection – Q0247

Sotrovimab Injection is a COVID-19 drug manufactured by GSK and administered via the Intravenous route of administration. The Q Code: Q0247 is aligned to the drug Sotrovimab Injection.

read more

BEBTELOVIMAB – Q0222

BEBTELOVIMAB is a COVID-19 drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The Q Code: Q0222 is aligned to the drug BEBTELOVIMAB.

read more